東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Preeclampsia = basic, genomic, and c...

SpringerLink (Online service)

FindBook

Google Book

Amazon

博客來

Preeclampsia = basic, genomic, and clinical /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Preeclampsia/ edited by Shigeru Saito.
其他題名:	basic, genomic, and clinical /
其他作者:	Saito, Shigeru.
出版者:	Singapore :Springer Singapore : : 2018.,
面頁冊數:	viii, 290 p. :ill., digital ;24 cm.
內容註:	Part 1 Risk factors for preeclampsia -- 1 Risk factors for preeclampsia- Part 2 Genetic background in preeclampsia- 2 Genetic background in preeclampsia -- Part 3 Pathological findings in preeclampsia- 3 Shallow trophoblast invasion and poor vascular remodeling -- Part 4 Pathophysiology of preeclampsia- 4 Immunological maladaptation -- 5 Glucose intolerance and insulin resistance -- 6 Placental adenosine signaling -- 7 Obesity and lipokine -- 8 Autophagy in preeclampsia. 9 Animal models in preeclampsia -- 10 The differencies between early onset and late onset preeclampsia -- Part 5 Predicton of preeclampsia- 11 sFlt-1/PlGF -- 12 Home blood pressure measurement -- 13 micro RNA -- Part 6 Therapy- 14 New therapies for preeclampsia -- 15 Statin therapy for preeclampsia -- 16 Prevension of stroke and eclampsia -- Part 7 The risk for cardiovascular event in preeclamtic cases- 17 The risk for cardiovascular event in preeclamtic cases.
Contained By:	Springer eBooks
標題:	Preeclampsia. -
電子資源:	http://dx.doi.org/10.1007/978-981-10-5891-2
ISBN:	9789811058912

Preeclampsia = basic, genomic, and clinical /
Preeclampsiabasic, genomic, and clinical /[electronic resource] :edited by Shigeru Saito. - Singapore :Springer Singapore :2018. - viii, 290 p. :ill., digital ;24 cm. - Comprehensive gynecology and obstetrics,2364-1932. - Comprehensive gynecology and obstetrics..

Part 1 Risk factors for preeclampsia -- 1 Risk factors for preeclampsia- Part 2 Genetic background in preeclampsia- 2 Genetic background in preeclampsia -- Part 3 Pathological findings in preeclampsia- 3 Shallow trophoblast invasion and poor vascular remodeling -- Part 4 Pathophysiology of preeclampsia- 4 Immunological maladaptation -- 5 Glucose intolerance and insulin resistance -- 6 Placental adenosine signaling -- 7 Obesity and lipokine -- 8 Autophagy in preeclampsia. 9 Animal models in preeclampsia -- 10 The differencies between early onset and late onset preeclampsia -- Part 5 Predicton of preeclampsia- 11 sFlt-1/PlGF -- 12 Home blood pressure measurement -- 13 micro RNA -- Part 6 Therapy- 14 New therapies for preeclampsia -- 15 Statin therapy for preeclampsia -- 16 Prevension of stroke and eclampsia -- Part 7 The risk for cardiovascular event in preeclamtic cases- 17 The risk for cardiovascular event in preeclamtic cases.

This volume is an excellent guide that comprehensively illustrates hypertensive disorders of pregnancy, especially preeclampsia, in both the basic and clinical aspects. Preeclampsia is a pregnancy-specific multi-organ disorder and a leading cause of maternal and neonatal mortality. The pathophysiology of pregnancy-specific disorders was long unknown, but recently many new findings have been reported from the point of view of pathophysiology. Furthermore, this complication of pregnancy, especially preeclampsia, is a potent risk factor for chronic conditions such as cardiovascular disease, diabetes mellitus, kidney disease, and hypertension. The book is composed of seven parts including genetic background, pathology, pathophysiology, and the latest prediction and treatment of preeclampsia. Specific basic topics such as immunological maladaptation, placental adenosine signaling, and new prediction markers are also expounded by experts. Thus it benefits not only obstetricians, pediatricians, nephrologists, diabetologists, and cardiologists, but also immunologists, endocrinologists, geneticists, pathologists, biologists, and molecular biologists who are interested in the treatment of hypertension in pregnancy.

ISBN: 9789811058912

Standard No.: 10.1007/978-981-10-5891-2doiSubjects--Topical Terms:

3309225
Preeclampsia.

LC Class. No.: RG575.5 / .P74 2018

Dewey Class. No.: 618.36132

Preeclampsia = basic, genomic, and clinical /
LDR:03166nmm a2200325 a 4500 001 2137149
003 DE-He213
005 20181012093336.0
006 m d
007 cr nn 008maaau
008 181117s2018 si s 0 eng d
020 $a 9789811058912 $q (electronic bk.)
020 $a 9789811058905 $q (paper)
024 7 $a 10.1007/978-981-10-5891-2 $2 doi
035 $a 978-981-10-5891-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RG575.5 $b .P74 2018
072 7 $a MJT $2 bicssc
072 7 $a MED033000 $2 bisacsh
082 0 4 $a 618.36132 $2 23
090 $a RG575.5 $b .P923 2018
245 0 0 $a Preeclampsia $h [electronic resource] : $b basic, genomic, and clinical / $c edited by Shigeru Saito.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2018.
300 $a viii, 290 p. : $b ill., digital ; $c 24 cm.
490 1 $a Comprehensive gynecology and obstetrics, $x 2364-1932
505 0 $a Part 1 Risk factors for preeclampsia -- 1 Risk factors for preeclampsia- Part 2 Genetic background in preeclampsia- 2 Genetic background in preeclampsia -- Part 3 Pathological findings in preeclampsia- 3 Shallow trophoblast invasion and poor vascular remodeling -- Part 4 Pathophysiology of preeclampsia- 4 Immunological maladaptation -- 5 Glucose intolerance and insulin resistance -- 6 Placental adenosine signaling -- 7 Obesity and lipokine -- 8 Autophagy in preeclampsia. 9 Animal models in preeclampsia -- 10 The differencies between early onset and late onset preeclampsia -- Part 5 Predicton of preeclampsia- 11 sFlt-1/PlGF -- 12 Home blood pressure measurement -- 13 micro RNA -- Part 6 Therapy- 14 New therapies for preeclampsia -- 15 Statin therapy for preeclampsia -- 16 Prevension of stroke and eclampsia -- Part 7 The risk for cardiovascular event in preeclamtic cases- 17 The risk for cardiovascular event in preeclamtic cases.
520 $a This volume is an excellent guide that comprehensively illustrates hypertensive disorders of pregnancy, especially preeclampsia, in both the basic and clinical aspects. Preeclampsia is a pregnancy-specific multi-organ disorder and a leading cause of maternal and neonatal mortality. The pathophysiology of pregnancy-specific disorders was long unknown, but recently many new findings have been reported from the point of view of pathophysiology. Furthermore, this complication of pregnancy, especially preeclampsia, is a potent risk factor for chronic conditions such as cardiovascular disease, diabetes mellitus, kidney disease, and hypertension. The book is composed of seven parts including genetic background, pathology, pathophysiology, and the latest prediction and treatment of preeclampsia. Specific basic topics such as immunological maladaptation, placental adenosine signaling, and new prediction markers are also expounded by experts. Thus it benefits not only obstetricians, pediatricians, nephrologists, diabetologists, and cardiologists, but also immunologists, endocrinologists, geneticists, pathologists, biologists, and molecular biologists who are interested in the treatment of hypertension in pregnancy.
650 0 $a Preeclampsia. $3 3309225
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Obstetrics/Perinatology/Midwifery. $3 3252304
650 2 4 $a Pediatrics. $3 559143
650 2 4 $a Cardiology. $3 861477
650 2 4 $a Nephrology. $3 894870
650 2 4 $a Diabetes. $3 544344
700 1 $a Saito, Shigeru. $3 2191947
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Comprehensive gynecology and obstetrics. $3 3259247
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-5891-2
950 $a Medicine (Springer-11650)